United States Oncology Drugs Market Report & Forecast 2021-2027

United States Oncology Drugs Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Oncology Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Oncology Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Oncology Drugs Overall Market Size
2.1 United States Oncology Drugs Market Size: 2021 VS 2027
2.2 United States Oncology Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Drugs Players in United States Market
3.2 Top United States Oncology Drugs Companies Ranked by Revenue
3.3 United States Oncology Drugs Revenue by Companies
3.4 Top 3 and Top 5 Oncology Drugs Companies in United States Market, by Revenue in 2020
3.5 Companies Oncology Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Drugs Players in United States Market
3.6.1 List of Tier 1 Oncology Drugs Companies in United States
3.6.2 List of Tier 2 and Tier 3 Oncology Drugs Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Oncology Drugs Market Size Markets, 2021 & 2027
4.1.2 Chemotherapy
4.1.3 Targeted Therapy
4.1.4 Immunotherapy (Biologic Therapy)
4.1.5 Hormonal Therapy
4.1.6 Others
4.2 By Type - United States Oncology Drugs Revenue & Forecasts
4.2.1 By Type - United States Oncology Drugs Revenue, 2016-2021
4.2.2 By Type - United States Oncology Drugs Revenue, 2022-2027
4.2.3 By Type - United States Oncology Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Oncology Drugs Market Size, 2021 & 2027
5.1.2 Blood Cancer
5.1.3 Breast Cancer
5.1.4 Gastrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Respiratory or Lung Cancer
5.1.7 Others
5.2 By Application - United States Oncology Drugs Revenue & Forecasts
5.2.1 By Application - United States Oncology Drugs Revenue, 2016-2021
5.2.2 By Application - United States Oncology Drugs Revenue, 2022-2027
5.2.3 By Application - United States Oncology Drugs Revenue Market Share, 2016-2027
6 Oncology Drugs Companies Profiles
6.1 Roche
6.1.1 Roche Company Details
6.1.2 Roche Business Overview
6.1.3 Roche Oncology Drugs Introduction
6.1.4 Roche Oncology Drugs Revenue in United States Market (2016-2021)
6.1.5 Roche Recent Developments
6.2 Celgene
6.2.1 Celgene Company Details
6.2.2 Celgene Business Overview
6.2.3 Celgene Oncology Drugs Introduction
6.2.4 Celgene Oncology Drugs Revenue in United States Market (2016-2021)
6.2.5 Celgene Recent Developments
6.3 Novartis
6.3.1 Novartis Company Details
6.3.2 Novartis Business Overview
6.3.3 Novartis Oncology Drugs Introduction
6.3.4 Novartis Oncology Drugs Revenue in United States Market (2016-2021)
6.3.5 Novartis Recent Developments
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Company Details
6.4.2 Bristol-Myers Squibb Business Overview
6.4.3 Bristol-Myers Squibb Oncology Drugs Introduction
6.4.4 Bristol-Myers Squibb Oncology Drugs Revenue in United States Market (2016-2021)
6.4.5 Bristol-Myers Squibb Recent Developments
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Details
6.5.2 Johnson & Johnson Business Overview
6.5.3 Johnson & Johnson Oncology Drugs Introduction
6.5.4 Johnson & Johnson Oncology Drugs Revenue in United States Market (2016-2021)
6.5.5 Johnson & Johnson Recent Developments
6.6 Merck & Co.
6.6.1 Merck & Co. Company Details
6.6.2 Merck & Co. Business Overview
6.6.3 Merck & Co. Oncology Drugs Introduction
6.6.4 Merck & Co. Oncology Drugs Revenue in United States Market (2016-2021)
6.6.5 Merck & Co. Recent Developments
6.7 AstraZeneca
6.7.1 AstraZeneca Company Details
6.7.2 AstraZeneca Business Overview
6.7.3 AstraZeneca Oncology Drugs Introduction
6.7.4 AstraZeneca Oncology Drugs Revenue in United States Market (2016-2021)
6.7.5 AstraZeneca Recent Developments
6.8 Pfizer
6.8.1 Pfizer Company Details
6.8.2 Pfizer Business Overview
6.8.3 Pfizer Oncology Drugs Introduction
6.8.4 Pfizer Oncology Drugs Revenue in United States Market (2016-2021)
6.8.5 Pfizer Recent Developments
6.9 Amgen
6.9.1 Amgen Company Details
6.9.2 Amgen Business Overview
6.9.3 Amgen Oncology Drugs Introduction
6.9.4 Amgen Oncology Drugs Revenue in United States Market (2016-2021)
6.9.5 Amgen Recent Developments
6.10 Eli Lilly
6.10.1 Eli Lilly Company Details
6.10.2 Eli Lilly Business Overview
6.10.3 Eli Lilly Oncology Drugs Introduction
6.10.4 Eli Lilly Oncology Drugs Revenue in United States Market (2016-2021)
6.10.5 Eli Lilly Recent Developments
6.11 AbbVie
6.11.1 AbbVie Company Details
6.11.2 AbbVie Business Overview
6.11.3 AbbVie Oncology Drugs Introduction
6.11.4 AbbVie Oncology Drugs Revenue in United States Market (2016-2021)
6.11.5 AbbVie Recent Developments
6.12 Takeda
6.12.1 Takeda Company Details
6.12.2 Takeda Business Overview
6.12.3 Takeda Oncology Drugs Introduction
6.12.4 Takeda Oncology Drugs Revenue in United States Market (2016-2021)
6.12.5 Takeda Recent Developments
6.13 Astellas
6.13.1 Astellas Company Details
6.13.2 Astellas Business Overview
6.13.3 Astellas Oncology Drugs Introduction
6.13.4 Astellas Oncology Drugs Revenue in United States Market (2016-2021)
6.13.5 Astellas Recent Developments
6.14 Ipsen
6.14.1 Ipsen Company Details
6.14.2 Ipsen Business Overview
6.14.3 Ipsen Oncology Drugs Introduction
6.14.4 Ipsen Oncology Drugs Revenue in United States Market (2016-2021)
6.14.5 Ipsen Recent Developments
6.15 Sanofi
6.15.1 Sanofi Company Details
6.15.2 Sanofi Business Overview
6.15.3 Sanofi Oncology Drugs Introduction
6.15.4 Sanofi Oncology Drugs Revenue in United States Market (2016-2021)
6.15.5 Sanofi Recent Developments
6.16 Bayer
6.16.1 Bayer Company Details
6.16.2 Bayer Business Overview
6.16.3 Bayer Oncology Drugs Introduction
6.16.4 Bayer Oncology Drugs Revenue in United States Market (2016-2021)
6.16.5 Bayer Recent Developments
6.17 Biogen Idec
6.17.1 Biogen Idec Company Details
6.17.2 Biogen Idec Business Overview
6.17.3 Biogen Idec Oncology Drugs Introduction
6.17.4 Biogen Idec Oncology Drugs Revenue in United States Market (2016-2021)
6.17.5 Biogen Idec Recent Developments
6.18 Teva
6.18.1 Teva Company Details
6.18.2 Teva Business Overview
6.18.3 Teva Oncology Drugs Introduction
6.18.4 Teva Oncology Drugs Revenue in United States Market (2016-2021)
6.18.5 Teva Recent Developments
6.19 Otsuka
6.19.1 Otsuka Company Details
6.19.2 Otsuka Business Overview
6.19.3 Otsuka Oncology Drugs Introduction
6.19.4 Otsuka Oncology Drugs Revenue in United States Market (2016-2021)
6.19.5 Otsuka Recent Developments
6.20 Eisai
6.20.1 Eisai Company Details
6.20.2 Eisai Business Overview
6.20.3 Eisai Oncology Drugs Introduction
6.20.4 Eisai Oncology Drugs Revenue in United States Market (2016-2021)
6.20.5 Eisai Recent Developments
6.21 Merck KGaA
6.21.1 Merck KGaA Company Details
6.21.2 Merck KGaA Business Overview
6.21.3 Merck KGaA Oncology Drugs Introduction
6.21.4 Merck KGaA Oncology Drugs Revenue in United States Market (2016-2021)
6.21.5 Merck KGaA Recent Developments
6.22 Gilead Sciences
6.22.1 Gilead Sciences Company Details
6.22.2 Gilead Sciences Business Overview
6.22.3 Gilead Sciences Oncology Drugs Introduction
6.22.4 Gilead Sciences Oncology Drugs Revenue in United States Market (2016-2021)
6.22.5 Gilead Sciences Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Oncology Drugs Market Opportunities & Trends in United States Market
Table 2. Oncology Drugs Market Drivers in United States Market
Table 3. Oncology Drugs Market Restraints in United States Market
Table 4. Key Players of Oncology Drugs in United States Market
Table 5. Top Oncology Drugs Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Oncology Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Oncology Drugs Revenue Share by Companies, 2016-2021
Table 8. Companies Oncology Drugs Product Type
Table 9. List of Tier 1 Oncology Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Oncology Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Oncology Drugs Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Oncology Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Oncology Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Oncology Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Oncology Drugs Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Oncology Drugs Revenue (US$, Mn), 2022-2027
Table 17. Roche Company Details
Table 18. Roche Business Overview
Table 19. Roche Oncology Drugs Product
Table 20. Roche Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Roche Recent Developments
Table 22. Celgene Company Details
Table 23. Celgene Business Overview
Table 24. Celgene Oncology Drugs Product
Table 25. Celgene Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Celgene Recent Developments
Table 27. Novartis Company Details
Table 28. Novartis Business Overview
Table 29. Novartis Oncology Drugs Product
Table 30. Novartis Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Novartis Recent Developments
Table 32. Bristol-Myers Squibb Company Details
Table 33. Bristol-Myers Squibb Business Overview
Table 34. Bristol-Myers Squibb Oncology Drugs Product
Table 35. Bristol-Myers Squibb Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Bristol-Myers Squibb Recent Developments
Table 37. Johnson & Johnson Company Details
Table 38. Johnson & Johnson Business Overview
Table 39. Johnson & Johnson Oncology Drugs Product
Table 40. Johnson & Johnson Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Johnson & Johnson Recent Developments
Table 42. Merck & Co. Company Details
Table 43. Merck & Co. Business Overview
Table 44. Merck & Co. Oncology Drugs Product
Table 45. Merck & Co. Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Merck & Co. Recent Developments
Table 47. AstraZeneca Company Details
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca Oncology Drugs Product
Table 50. AstraZeneca Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. AstraZeneca Recent Developments
Table 52. Pfizer Company Details
Table 53. Pfizer Business Overview
Table 54. Pfizer Oncology Drugs Product
Table 55. Pfizer Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Pfizer Recent Developments
Table 57. Amgen Company Details
Table 58. Amgen Business Overview
Table 59. Amgen Oncology Drugs Product
Table 60. Amgen Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Amgen Recent Developments
Table 62. Eli Lilly Company Details
Table 63. Eli Lilly Business Overview
Table 64. Eli Lilly Oncology Drugs Product
Table 65. Eli Lilly Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Eli Lilly Recent Developments
Table 67. AbbVie Company Details
Table 68. AbbVie Business Overview
Table 69. AbbVie Oncology Drugs Product
Table 70. AbbVie Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. AbbVie Recent Developments
Table 72. Takeda Company Details
Table 73. Takeda Business Overview
Table 74. Takeda Oncology Drugs Product
Table 75. Takeda Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. Takeda Recent Developments
Table 77. Astellas Company Details
Table 78. Astellas Business Overview
Table 79. Astellas Oncology Drugs Product
Table 80. Astellas Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 81. Astellas Recent Developments
Table 82. Ipsen Company Details
Table 83. Ipsen Business Overview
Table 84. Ipsen Oncology Drugs Product
Table 85. Ipsen Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 86. Ipsen Recent Developments
Table 87. Sanofi Business Overview
Table 88. Sanofi Company Details
Table 89. Sanofi Oncology Drugs Product
Table 90. Sanofi Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 91. Sanofi Recent Developments
Table 92. Bayer Company Details
Table 93. Bayer Business Overview
Table 94. Bayer Oncology Drugs Product
Table 95. Bayer Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 96. Bayer Recent Developments
Table 97. Biogen Idec Company Details
Table 98. Biogen Idec Business Overview
Table 99. Biogen Idec Oncology Drugs Product
Table 100. Biogen Idec Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 101. Biogen Idec Recent Developments
Table 102. Teva Company Details
Table 103. Teva Business Overview
Table 104. Teva Oncology Drugs Product
Table 105. Teva Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 106. Teva Recent Developments
Table 107. Otsuka Company Details
Table 108. Otsuka Business Overview
Table 109. Otsuka Oncology Drugs Product
Table 110. Otsuka Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 111. Otsuka Recent Developments
Table 112. Eisai Company Details
Table 113. Eisai Business Overview
Table 114. Eisai Oncology Drugs Product
Table 115. Eisai Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 116. Eisai Recent Developments
Table 117. Merck KGaA Company Details
Table 118. Merck KGaA Business Overview
Table 119. Merck KGaA Oncology Drugs Product
Table 120. Merck KGaA Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 121. Merck KGaA Recent Developments
Table 122. Gilead Sciences Company Details
Table 123. Gilead Sciences Business Overview
Table 124. Gilead Sciences Oncology Drugs Product
Table 125. Gilead Sciences Oncology Drugs Revenue in United States Market (2016-2021) & (US$ Million)
Table 126. Gilead Sciences Recent Developments
List of Figures
Figure 1. Oncology Drugs Segment by Type
Figure 2. Oncology Drugs Segment by Application
Figure 3. United States Oncology Drugs Market Overview: 2020
Figure 4. United States Oncology Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Oncology Drugs Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Oncology Drugs Revenue in 2020
Figure 7. By Type - United States Oncology Drugs Revenue Market Share, 2016-2027
Figure 8. By Application - United States Oncology Drugs Revenue Market Share, 2016-2027
Figure 9. Roche Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Celgene Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Novartis Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Bristol-Myers Squibb Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Johnson & Johnson Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Merck & Co. Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. AstraZeneca Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Pfizer Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Amgen Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Eli Lilly Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. AbbVie Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Takeda Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Astellas Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Ipsen Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Sanofi Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Bayer Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Biogen Idec Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Teva Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Otsuka Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Eisai Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Merck KGaA Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Gilead Sciences Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs